Gefitinib

Date 27 June 2014
Event 4th International Conference on Thoracic Oncology
Session Special symposium I - Treatment of NSCLC with activating EGFR mutation: Who is the better?
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Presenter T. Mok